Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3990 |  ICCC ImmuCell Corporation - Common Stock | 10.00 USD | -0.60% | +0.60% | -9.91% | +64.47% | 90.82 M USD | ||
| 3997 |  RLYB Rallybio Corporation - Common Stock | 16.54 USD | -2.42% | -3.84% | +0.43% | +2567.74% | 87.84 M USD | ||
| 4010 |  GANX Gain Therapeutics, Inc. - Common Stock | 1.95 USD | -2.99% | -6.70% | +8.94% | -1.52% | 85.11 M USD | ||
| 4019 |  ACET Adicet Bio, Inc. - Common Stock | 8.85 USD | -3.70% | +2.08% | +12.17% | +1112.33% | 82.85 M USD | ||
| 4024 |  ELOX Eloxx Pharmaceuticals, Inc. | 19.78 USD | -5.67% | +7.68% | +67.77% | +97.80% | 79.84 M USD | ||
| 4027 |  MAIA MAIA Biotechnology, Inc. Common Stock | 1.34 USD | -3.60% | -1.47% | +3.88% | -35.58% | 81.51 M USD | ||
| 4040 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 4.76 USD | -1.24% | -4.99% | -6.30% | -20.93% | 81.77 M USD | ||
| 4049 |  OKYO OKYO Pharma Limited - American Depositary Shares | 1.54 USD | 0.00% | +1.32% | -0.65% | -40.77% | 80.82 M USD | ||
| 4052 |  CING Cingulate Inc. - Common Stock | 5.46 USD | -1.62% | +4.60% | +16.17% | -11.36% | 79.40 M USD | ||
| 4063 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 2.99 USD | -1.64% | -2.92% | -2.92% | -70.10% | 78.58 M USD | ||
| 4075 |  TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.16 USD | +2.65% | +8.41% | 0.00% | -20.00% | 79.78 M USD | ||
| 4077 |  ANVS Annovis Bio, Inc. Common Stock | 1.77 USD | -2.75% | -2.21% | +5.99% | -25.94% | 75.41 M USD | ||
| 4079 |  NRXS Neuraxis, Inc. Common Stock | 6.02 USD | -2.11% | -6.81% | -10.28% | +10.87% | 75.60 M USD | ||
| 4108 |  GOSS Gossamer Bio, Inc. - Common Stock | 0.15 USD | 0.00% | 0.00% | -11.76% | -93.59% | 73.33 M USD | ||
| 4110 |  SER Serina Therapeutics, Inc. Common Stock | 2.82 USD | -1.74% | +1.44% | +41.00% | +68.86% | 71.63 M USD | ||
| 4113 |  LONA LeonaBio, Inc. - Common Stock | 7.60 USD | -1.04% | -4.04% | +2.70% | +12.76% | 71.60 M USD | ||
| 4118 |  PLRX Pliant Therapeutics, Inc. - Common Stock | 1.13 USD | -2.59% | +2.73% | +4.63% | -22.07% | 69.97 M USD | ||
| 4127 |  PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.32 USD | -0.75% | +4.76% | +6.45% | -11.41% | 70.56 M USD | ||
| 4128 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.21 USD | -0.82% | -0.82% | -0.82% | -35.98% | 70.46 M USD | ||
| 4129 |  IBIO iBio, Inc. - Common Stock | 1.39 USD | -2.80% | -5.44% | -3.47% | -39.57% | 69.05 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |